News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
238,658 Results
Type
Article (22742)
Company Profile (111)
Press Release (215805)
Section
Business (63797)
Career Advice (308)
Deals (9725)
Drug Delivery (37)
Drug Development (41672)
Employer Resources (23)
FDA (5264)
Job Trends (5312)
News (119185)
Policy (9740)
Tag
Academia (1130)
Alliances (19135)
Alzheimer's disease (257)
Antibody-drug conjugate (ADC) (86)
Approvals (5255)
Artificial intelligence (72)
Bankruptcy (81)
Best Places to Work (4629)
Biotechnology (93)
Breast cancer (201)
Cancer (1450)
Career advice (293)
CAR-T (85)
Cell therapy (199)
Clinical research (33218)
Collaboration (251)
Compensation (74)
COVID-19 (698)
C-suite (40)
Data (742)
Diabetes (45)
Diagnostics (3271)
Earnings (21506)
Events (39821)
Executive appointments (155)
FDA (5531)
Funding (175)
Gene therapy (57)
GLP-1 (173)
Government (1459)
Healthcare (6977)
Infectious disease (731)
Inflammatory bowel disease (44)
IPO (5017)
Job creations (932)
Job search strategy (281)
Layoffs (152)
Legal (1582)
Liver cancer (70)
Lung cancer (218)
Lymphoma (95)
Manufacturing (63)
Medical device (2242)
Medtech (2243)
Mergers & acquisitions (4757)
Metabolic disorders (109)
Neuroscience (311)
NextGen Class of 2024 (2018)
Non-profit (1794)
Northern California (740)
Obesity (57)
Opinion (68)
Ovarian cancer (49)
Pancreatic cancer (51)
Patents (41)
People (19279)
Phase I (12231)
Phase II (14421)
Phase III (10052)
Pipeline (253)
Postmarket research (1105)
Preclinical (4997)
Prostate cancer (69)
Radiopharmaceuticals (227)
Rare diseases (79)
Real estate (1589)
Regulatory (7341)
Research institute (1374)
Southern California (605)
Startups (1329)
United States (5853)
Vaccines (196)
Date
Today (53)
Last 7 days (228)
Last 30 days (1095)
Last 365 days (14615)
2024 (14553)
2023 (16384)
2022 (21161)
2021 (21869)
2020 (19097)
2019 (15748)
2018 (11586)
2017 (12383)
2016 (11656)
2015 (13575)
2014 (10037)
2013 (8119)
2012 (8177)
2011 (8625)
2010 (8049)
Location
Africa (228)
Arizona (44)
Asia (16433)
Australia (3434)
California (1537)
Canada (575)
China (186)
Colorado (54)
Connecticut (66)
Delaware (51)
Europe (37864)
Florida (187)
Georgia (43)
Illinois (139)
Indiana (85)
Maryland (266)
Massachusetts (1145)
Minnesota (80)
New Jersey (537)
New York (504)
North Carolina (215)
Northern California (740)
Ohio (45)
Pennsylvania (248)
South America (256)
Southern California (605)
Texas (312)
Washington State (206)
238,658 Results for "peter maccallum cancer centre".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX’s CAR-T cell therapy in patients with kappa-type myeloma.
July 25, 2023
·
3 min read
Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Ovarian Cancer
Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced today they have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy (CTH-004) for the treatment of ovarian cancer.
February 27, 2023
·
5 min read
Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Cutaneous T-Cell Lymphoma
The Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced today they have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy (CTH-001) for the treatment of cutaneous T-cell lymphoma (CTCL).
November 8, 2022
·
4 min read
Press Releases
On Target Laboratories Appoints Bill Peters as CEO
December 11, 2024
·
3 min read
Antibody-drug conjugate (ADC)
AstraZeneca, Daiichi Sankyo’s ADC Flops in Phase III Breast Cancer on Heels of Lung Cancer Stumble
Monday’s failure to improve overall survival in breast cancer “further dents belief” in the companies’ Dato-DXd and “likely complicates regulatory discussions for approval of this indication,” Jefferies analyst Peter Welford wrote in a note to investors.
September 23, 2024
·
3 min read
·
Tristan Manalac
Press Releases
March Biosciences Elects Peter Olagunju as Chair of Board of Directors
December 20, 2024
·
4 min read
Business
Isotopia and the Peter MacCallum Cancer Centre announce Terbium-161 clinical study collaboration
Peter MacCallum Cancer Centre, world leading cancer research, education and treatment center and Isotopia Molecular Imaging Limited (Isotopia), a global supplier of radioisotopes for targeted therapies, today announced they have signed a clinical research and supply agreement for the medical radioisotope no-carrier-added Terbium-161 (n.c.a. Tb-161).,
November 9, 2021
·
3 min read
Biotech Bay
BridGene Biosciences Announces Research Collaboration with the Peter MacCallum Cancer Centre to Discover Targets and Small Molecule Drug Candidates for Ovarian Cancer
BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules for high value, traditionally undruggable targets, today announced a research collaboration agreement with the Peter MacCallum Cancer Centre (Peter Mac), a world leading research, education, and treatment center in Melbourne, Australia.
December 15, 2021
·
4 min read
Press Releases
Amarin Appoints Peter Fishman Chief Financial Officer
December 13, 2024
·
4 min read
Press Releases
Iambic Therapeutics Announces Appointment of Peter Olson, Ph.D., as Chief Scientific Officer
December 11, 2024
·
3 min read
1 of 23,866
Next